T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $883B
1-Year Return 25.8%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Quarter Return
-2.48%
1 Year Return
+25.8%
3 Year Return
+128.18%
5 Year Return
+198.37%
10 Year Return
+601.91%
AUM
$812B
AUM Growth
-$55.5B
Cap. Flow
-$16.7B
Cap. Flow %
-2.05%
Top 10 Hldgs %
32.22%
Holding
3,103
New
89
Increased
2,002
Reduced
738
Closed
61

Sector Composition

1 Technology 30.49%
2 Healthcare 13.92%
3 Financials 12.27%
4 Consumer Discretionary 10.96%
5 Communication Services 9.27%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
SGMT icon
2926
Sagimet Biosciences
SGMT
$220M
$43K ﹤0.01%
+12,918
New +$43K
SLDB icon
2927
Solid Biosciences
SLDB
$420M
$43K ﹤0.01%
+11,558
New +$43K
BGFV icon
2928
Big 5 Sporting Goods
BGFV
$32.8M
$42K ﹤0.01%
42,900
BMEA icon
2929
Biomea Fusion
BMEA
$115M
$42K ﹤0.01%
19,352
SERA icon
2930
Sera Prognostics
SERA
$118M
$42K ﹤0.01%
11,333
TOON icon
2931
Kartoon Studios
TOON
$37.8M
$42K ﹤0.01%
66,240
PED icon
2932
PEDEVCO
PED
$54.8M
$41K ﹤0.01%
57,500
BEEM icon
2933
Beam Global
BEEM
$41.4M
$40K ﹤0.01%
19,600
QIPT
2934
Quipt Home Medical
QIPT
$117M
$40K ﹤0.01%
16,802
+1,031
+7% +$2.45K
SCPH icon
2935
scPharmaceuticals
SCPH
$302M
$40K ﹤0.01%
15,143
CHRS icon
2936
Coherus Oncology, Inc. Common Stock
CHRS
$150M
$39K ﹤0.01%
48,153
+7,984
+20% +$6.47K
KG
2937
Kestrel Group, Ltd.
KG
$211M
$39K ﹤0.01%
3,402
PROK icon
2938
ProKidney
PROK
$335M
$38K ﹤0.01%
43,108
+2,630
+6% +$2.32K
LXEO icon
2939
Lexeo Therapeutics
LXEO
$280M
$37K ﹤0.01%
10,425
PMVP icon
2940
PMV Pharmaceuticals
PMVP
$65.2M
$37K ﹤0.01%
33,600
ACHV icon
2941
Achieve Life Sciences
ACHV
$157M
$36K ﹤0.01%
13,474
BTMD icon
2942
Biote Corp
BTMD
$107M
$36K ﹤0.01%
10,709
DIBS icon
2943
1stdibs.com
DIBS
$101M
$36K ﹤0.01%
+11,728
New +$36K
LRMR icon
2944
Larimar Therapeutics
LRMR
$336M
$36K ﹤0.01%
16,310
+858
+6% +$1.89K
UP icon
2945
Wheels Up
UP
$1.52B
$36K ﹤0.01%
35,275
ATOS icon
2946
Atossa Therapeutics
ATOS
$108M
$35K ﹤0.01%
51,198
DXLG icon
2947
Destination XL Group
DXLG
$80.3M
$35K ﹤0.01%
23,334
QVCGA
2948
QVC Group, Inc. Series A Common Stock
QVCGA
$92M
$35K ﹤0.01%
3,417
MURA icon
2949
Mural Oncology
MURA
$36M
$34K ﹤0.01%
26,905
SGHT icon
2950
Sight Sciences
SGHT
$181M
$34K ﹤0.01%
13,756